Illumina Shares Drop 13% After-Hours Despite Raised Annual Guidance and Q3 Earnings Beat
Illumina (ILMN) shares fell approximately 13% in after-hours trading following its third-quarter earnings report. Although the DNA sequencing company exceeded expectations on the bottom line with a quarterly earnings beat, it failed to meet top-line revenue estimates. Despite the immediate stock decline, Illumina raised its full-year 2026 guidance for both revenue and non-GAAP diluted earnings per share (EPS). The market reaction suggests investor concern over the revenue miss despite the improved long-term financial outlook.
Tickers: $ILMN